Insider Transactions in Q4 2022 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
David D. Meek Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,616
-6.63%
|
$184,640
$40.41 P/Share
|
|
Dec 21
2022
|
Benjamin Hickey EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,248
-6.0%
|
$129,920
$40.41 P/Share
|
|
Dec 21
2022
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
9,092
-5.01%
|
$363,680
$40.42 P/Share
|
|
Dec 19
2022
|
David D. Meek Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,425
+33.73%
|
-
|
|
Dec 19
2022
|
Benjamin Hickey EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,149
+26.13%
|
-
|
|
Dec 19
2022
|
Charles M Baum Founder, President, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,618
+22.8%
|
-
|
|
Dec 16
2022
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,410
-2.31%
|
$103,630
$43.0 P/Share
|
|
Dec 02
2022
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,726
-1.63%
|
$155,340
$90.19 P/Share
|
|
Nov 28
2022
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
69,256
-35.13%
|
$6,925,600
$100.0 P/Share
|
|
Nov 28
2022
|
Charles M Baum Founder, President, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,256
+26.0%
|
$1,177,352
$17.41 P/Share
|
|
Nov 07
2022
|
Alan B. Sandler Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|